I made yet another shares purchase today and this time round, the company picked was C&O Pharmaceutical Technology Limited [E92.SI].
The main reason why I bought this C&O is due to impressive to-come dividends. As anticipated by Philip Research, 4Q dividend could be at S$0.012 which makes the whole year dividend to be at S$0.08. If we were to use today's S$0.47/share, it would be 17%! This very healthy net cash comes after they sold Hong kong asset, which add to their EPS.
1 past dividend and 1 coming soon
Ex Date: 26 Aug 2010 SGD 0.028
Ex Date: 12 Jul 2010 SGD 0.005
Ex Date: 12 Jul 2010 SGD 0.035
This China-based drug maker's strong R&D capability provides springboard to launch new products, paving way for expansion in local and international markets. According to CIMB analyst, C&O is also an attractive partner to foreign drug companies looking to enter the China market.
Stay invested for the dividends remain my key investment strategy.
Subscribe to:
Post Comments (Atom)
-
Google url shortener service, goo.gl , is now much improved with newly included features like easier copy and paste, and ability to delete e...
-
According to an article from the MSDN , DirectoryInfo.GetFiles() method will give unexpected behaviour on 3-letter extensions. I quote Micr...
-
Installed FortiClient recently but the challenge in disabling the application/service from running automatically on every start-up annoyed m...
-
ActiveSG is a national initiative from the Singapore government to encourage all to stay healthy and keeping fit. Membership registration i...
No comments:
Post a Comment
Do provide your constructive comment. I appreciate that.